University of North Carolina at Chapel Hill ( Site 1042) — Chapel Hill, North Carolina

University of North Carolina at Chapel Hill ( Site 1042) is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of North Carolina at Chapel Hill ( Site 1042) has participated in 2 clinical trials.

Therapeutic areas: HIV Infection, Pulmonary Arterial Hypertension.

Sponsors: Merck Sharp & Dohme LLC, Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of North Carolina at Chapel Hill ( Site 1042)?

University of North Carolina at Chapel Hill ( Site 1042) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of North Carolina at Chapel Hill ( Site 1042) conducted?

University of North Carolina at Chapel Hill ( Site 1042) has 2 clinical trials on record. Their work covers HIV Infection, Pulmonary Arterial Hypertension.

Is University of North Carolina at Chapel Hill ( Site 1042) accredited by Crixeo Health?

University of North Carolina at Chapel Hill ( Site 1042) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of North Carolina at Chapel Hill ( Site 1042)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.